Avid Bioservices Inc (CDMO)

[itsabouttime]

Precisely why the developed bio markers of Bavi with its efficacy and method of action in combo treatments will be a more precise and cost effective treatment regimen that will reach the non responders which is the majority of the patients. Bavi is in this i/o space . It is about time.






___________________________________________________________________
"....The fact that we’re talking about giving indefinite Keytruda to the vast majority of patients with advanced NSCLC makes it a jackpot for Merck, but the fact is that many patients will not be benefiting from it, we have no way to know which ones are, and everyone else in society will be faced with the crushing weight of paying for this money grab....."

Again, perhaps PPHM can help to solve the problem posed.
____________________________________________________________________